Uveitis Clinical Trial
Official title:
Infectious Causes of Uveitis, With Special Focus on Infection With Leptospira
Uveitis is an inflammatory disease of one or both eyes. Uveitis will in severe cases lead to
permanent loss of vision/blindness on the affected eye. Uveitis can be caused by autoimmune
disease, infections and rarely trauma, but 50 % of the cases remain of unknown origin.
Intraocular infections are from previous studies, known to be responsible for approximately
40 % of the cases of severe forms of uveitis. Most infectious causes of uveitis have the
potential to be treated with antibiotic.
Most infectious causes of uveitis are under normal condition only possible to detect by
using very specific detection methods. Further more it is often necessary to study a sample
from with-in the eye (vitrectomy to get a proper diagnosis. The knowledge about witch kind
of infections that causes uveitis, are therefore limited to the kind of infections that are
tested for.
Our hypothesis are that infections are a frequent cause of severe uveitis in Denmark, and
that by using a broad diagnostic approach it is possible to identify new or less recognized
infections agents that are associated with uveitis. By this study we want to describe the
prevalence and distribution of infections among patients with severe uveitis. In this study
are we only including patients with a severe form of uveitis from a referral-hospital
setting, where vitrectomy is done for a diagnostic purpose.
The patients will undergo a standard diagnostic examination including the most common
infectious causes of uveitis. Beside this we will look for a broad range of infection, which
has previously been described in the litera-ture to cause uveitis, but are not normally
tested for. Further more, we will use broad ranged molecular diagnostic methods to look for
new previously unknown bacterial causes of uveitis. Such study has not previously been done
previously in Denmark. As control group are included patients that undergo vitrectomy for
due either one of the two diseases "epiretinal fibrosis or "macula hole". All patients and
controls will be interview using a standardized questionnaire about risk factors for
acquiring these infections.
All patients included eye examination that includes split-lamp examination with
semi-quantification evaluation of the inflammation, fundoscopy incl. picture, and
angiography.
Hemoglobin (Hb), Erythrocyte-volume fraction (EVF), Middle cell volume (MCV), middelcell
hemoglobin concentration (MCHC), Trombocyte
- Alanin-aminotransferase (ALAT), S-albumin, S-bilirubin (total), Protrombin complex,
INR.
- Na, K, creatinin,
- CRP, Leukocyte and differential count
- ACE (Angiotensin Converting Enzyme)
- S-Ca2+
X-ray of thorax
The biopsies taken from the patient are in the routine program are patients tested for
intraocular infections with Herpes Simplex Virus, Cytomegalovirus, Varicella Zoster virus,
Epstein-Barr virus and toxoplasma with PCR and serology on serum. Test for others infections
like Candida spp. and Toxocare are done if clini-cally indicated. Other test includes
cytopathological test of the corpus vitreum for cancer cells and serological test for
Syphilis.
Beside the above mentioned test will we in this study test for:
Infections with Leptospira, Bartonella, Brucella, Mycobacterium tuberculosis, Leptospira,
Toxocare, Borrelia, HIV.
We will use unspecific molecular test for Bacteria under a special setup to avoid DNA
contamination. Culture of Leptospira will be done on urine samples.
;
Observational Model: Cohort, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04101604 -
Biomarkers of Common Eye Diseases
|
||
| Active, not recruiting |
NCT04704609 -
Imaging Quantification of Inflammation (IQI)
|
||
| Completed |
NCT03173144 -
Chronic Inflammatory Disease, Lifestyle and Treatment Response
|
||
| Withdrawn |
NCT01280669 -
Intravitreal Sirolimus as Therapeutic Approach to Uveitis
|
Phase 2 | |
| Terminated |
NCT02907814 -
Measurement of Anterior Chamber Cell Grading Using Ocular Coherence Tomography
|
N/A | |
| Active, not recruiting |
NCT02252328 -
Use of Simvastatin as a Steroid Sparing Agent for Uveitis Patients
|
Phase 2/Phase 3 | |
| Completed |
NCT04183387 -
Simvastatin in Uveitis
|
Phase 2 | |
| Completed |
NCT01983488 -
Clinical Outcome in Uveitis
|
||
| Withdrawn |
NCT00499551 -
A Phase I/IIa Study for the Treatment of Uveitis With Iontophoresis
|
Phase 1/Phase 2 | |
| Completed |
NCT00132691 -
Multicenter Uveitis Steroid Treatment (MUST) Trial
|
Phase 4 | |
| Completed |
NCT00476593 -
Retinal OCT and (mfERG) Related to Age, Sex, and the Use of Anti-inflammatory Medications
|
N/A | |
| Terminated |
NCT00114062 -
Study to Treat Uveitis Associated Macular Edema
|
Phase 2 | |
| Completed |
NCT00001867 -
Effect of Pregnancy on Uveitis
|
N/A | |
| Completed |
NCT00379275 -
Eye and Immunogenetic Features of Sarcoidosis
|
N/A | |
| Active, not recruiting |
NCT03828019 -
Adalimumab vs. Conventional Immunosuppression for Uveitis Trial
|
Phase 3 | |
| Terminated |
NCT01939691 -
Macular Edema Nepafenac vs. Difluprednate Uveitis Trial
|
Phase 4 | |
| Active, not recruiting |
NCT03889860 -
Objective Choroidal Thickness Measurements in Uveitis
|
||
| Completed |
NCT00070759 -
Daclizumab to Treat Non-Infectious Sight-Threatening Uveitis
|
Phase 2 | |
| Recruiting |
NCT05486468 -
The Use of Two YUTIQ Versus Sham for Treatment of Chronic Non Infectious Intraocular Inflammation Affecting the Posterior Segment
|
Phase 3 | |
| Active, not recruiting |
NCT05385757 -
UNICORNS: Uveitis in Childhood Prospective National Cohort Study
|